US Stock MarketDetailed Quotes

IPSC Century Therapeutics

Watchlist
  • 0.909
  • +0.004+0.45%
Close Jan 17 16:00 ET
  • 0.909
  • 0.0000.00%
Post 16:02 ET
77.32MMarket Cap-0.50P/E (TTM)

Century Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Century Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 633.330K --
-- 2024/Q4 -- / 975.000K --
-- 2024/Q3 791.000K / 550.000K --
-- 2024/Q2 771.000K / 666.670K --
-- 2024/Q1 855.000K / 225.000K --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 633.330K--
--2024/Q4-- / 975.000K--
--2024/Q3791.000K / 550.000K--
--2024/Q2771.000K / 666.670K--
--2024/Q1855.000K / 225.000K--

Unlock Free Earnings Estimates

Century Therapeutics Earnings Reports

  • Century Therapeutics | 8-K: Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

    Nov 5, 2024 22:11

  • Century Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 5, 2024 22:11

  • Century Therapeutics | 8-K: Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates

    Aug 8, 2024 19:39

  • Century Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8, 2024 19:34

    • Read more

    Trending US Stocks
    Warren Buffett Portfolio Warren Buffett Portfolio

    Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
    Symbol Mini Chart % Chg
    Citigroup
    C
    +1.89%
    Chevron
    CVX
    +1.31%
    The Kraft Heinz
    KHC
    +1.04%
    DaVita
    DVA
    +0.84%
    Apple
    AAPL
    +0.75%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Strong Buy

    • Buy

      80.00%

    • Hold

      20.00%

    • Sell

      0.00%

    Price Target

    No Data